Gary Floyd
Geschäftsführer bei Sedor Pharmaceuticals LLC
Profil
Gary Floyd is currently a member of the American Association of Pharmaceutical Scientists and the Chief Operating Officer at Sedor Pharmaceuticals LLC.
He previously worked as the President & Director at Pharmavene, Inc., Chief Operating Officer at Cangene Corp., Vice President-Operations at Eximias Pharmaceutical Corp., Senior VP-Worldwide Logistics & Procurement at Aventis Behring, Vice President-Operations at YM Biosciences USA, Inc., Vice President-Sales, Marketing & Operations at Armour Pharmaceutical Co., and Senior VP-Worldwide Industrial Operations at Centeon LLC.
He obtained an undergraduate degree from Olivet Nazarene University.
Aktive Positionen von Gary Floyd
| Unternehmen | Position | Beginn |
|---|---|---|
American Association of Pharmaceutical Scientists
 American Association of Pharmaceutical Scientists BiotechnologyHealth Technology The American Association of Pharmaceutical Scientists engages in research and development of pharmaceutical products. The private company is based in Arlington, VA. The company was founded by Leslie Z. Benet. | Corporate Officer/Principal | - |
Sedor Pharmaceuticals LLC
 Sedor Pharmaceuticals LLC Financial ConglomeratesFinance Sedor Pharmaceuticals LLC is a pharmaceutical company that identifies, acquires, and develops acute care pharmaceutical assets for commercial licensing. The private company is based in Paoli, PA, and was founded by John A. Sedor and Barry R. Frankel. The company's lead product, Sesquient, has received FDA approval for the treatment of status epilepticus, and they are preparing to enter phase I development of their second product, Meloxicam for injection solubilized with betadex sulfobutyl ether sodium, for the potential treatment of acute post-surgical pain. Both products were licensed from Ligand Pharmaceuticals. The company is led by Chairman and CEO John Sedor and an experienced team of pharmaceutical professionals. John A. Sedor has been the CEO since incorporation. | Geschäftsführer | - |
Ehemalige bekannte Positionen von Gary Floyd
| Unternehmen | Position | Ende |
|---|---|---|
| Centeon LLC | Corporate Officer/Principal | - |
| CANGENE CORPORATION | Geschäftsführer | - |
| Aventis Behring | Corporate Officer/Principal | - |
Pharmavene, Inc.
 Pharmavene, Inc. Pharmaceuticals: MajorHealth Technology Pharmavene, Inc. develops pharmaceutical products. The company develops drug delivery and screening technologies to produce optimal delivery of particular pharmaceutical products. Its technologies include proprietary Peptitrol systems for oral delivery of hard-to-deliver compounds, oral controlled-release and sustained-release delivery, transmucosal delivery through tissues in oral cavity and transdermal delivery. Pharmavene is headquartered in Rockville, MD. | Präsident | - |
| Armour Pharmaceutical Co. | Geschäftsführer | - |
Ausbildung von Gary Floyd
| Olivet Nazarene University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
Eximias Pharmaceutical Corp.
 Eximias Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology Eximias Pharmaceutical Corp. develops pharmaceuticals for treatment of cancer disorders. It offers its services in the mid-Atlantic areas. The company is headquartered in Berwyn, PA. | Health Technology |
YM Biosciences USA, Inc.
 YM Biosciences USA, Inc. Pharmaceuticals: MajorHealth Technology YM Biosciences USA, Inc. develops and commercializes pharmaceutical products. The company was founded on November 23, 2005 and is headquartered in Wayne, PA. | Health Technology |
| Armour Pharmaceutical Co. | |
Pharmavene, Inc.
Pharmavene, Inc. Pharmaceuticals: MajorHealth Technology Pharmavene, Inc. develops pharmaceutical products. The company develops drug delivery and screening technologies to produce optimal delivery of particular pharmaceutical products. Its technologies include proprietary Peptitrol systems for oral delivery of hard-to-deliver compounds, oral controlled-release and sustained-release delivery, transmucosal delivery through tissues in oral cavity and transdermal delivery. Pharmavene is headquartered in Rockville, MD. | Health Technology |
| Aventis Behring | Health Technology |
| Centeon LLC | |
Cangene Corp.
 Cangene Corp. Pharmaceuticals: MajorHealth Technology Cangene Corp. developed, manufactured and sold biopharmaceutical drugs. The company was founded on February 22, 1984 and was headquartered in Winnipeg, Canada. | Health Technology |
American Association of Pharmaceutical Scientists
American Association of Pharmaceutical Scientists BiotechnologyHealth Technology The American Association of Pharmaceutical Scientists engages in research and development of pharmaceutical products. The private company is based in Arlington, VA. The company was founded by Leslie Z. Benet. | Health Technology |
Sedor Pharmaceuticals LLC
Sedor Pharmaceuticals LLC Financial ConglomeratesFinance Sedor Pharmaceuticals LLC is a pharmaceutical company that identifies, acquires, and develops acute care pharmaceutical assets for commercial licensing. The private company is based in Paoli, PA, and was founded by John A. Sedor and Barry R. Frankel. The company's lead product, Sesquient, has received FDA approval for the treatment of status epilepticus, and they are preparing to enter phase I development of their second product, Meloxicam for injection solubilized with betadex sulfobutyl ether sodium, for the potential treatment of acute post-surgical pain. Both products were licensed from Ligand Pharmaceuticals. The company is led by Chairman and CEO John Sedor and an experienced team of pharmaceutical professionals. John A. Sedor has been the CEO since incorporation. | Finance |
